CD4 and prostate cancer: Men with abundant CD163+ M2 macrophages in prostate tissue have a higher risk of lethal prostate cancer and the interpretation is that the presence of these suppressor cells, CD163+ M2 macrophages, and CD4+ FoxP3+ Tregs may promote an immunosuppressive microenvironment [72].